BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17634838)

  • 1. Treatment of Waldenstrom's Macroglobulinemia.
    Dimopoulos MA; Anagnostopoulos A
    Curr Treat Options Oncol; 2007 Apr; 8(2):144-53. PubMed ID: 17634838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia.
    Dimopoulos MA; Gertz MA; Kastritis E; Garcia-Sanz R; Kimby EK; Leblond V; Fermand JP; Merlini G; Morel P; Morra E; Ocio EM; Owen R; Ghobrial IM; Seymour J; Kyle RA; Treon SP
    J Clin Oncol; 2009 Jan; 27(1):120-6. PubMed ID: 19047284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
    Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Waldenström's macroglobulinemia: a review of therapy.
    Gertz MA
    Leuk Lymphoma; 2002 Aug; 43(8):1517-26. PubMed ID: 12400593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bortezomib as a treatment option in patients with Waldenström macroglobulinemia.
    Dimopoulos MA; Chen C; Kastritis E; Gavriatopoulou M; Treon SP
    Clin Lymphoma Myeloma Leuk; 2010 Apr; 10(2):110-7. PubMed ID: 20371443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of Waldenstrom's macroglobulinemia.
    Dimopoulos MA; Kyle RA; Anagnostopoulos A; Treon SP
    J Clin Oncol; 2005 Mar; 23(7):1564-77. PubMed ID: 15735132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How we treat Waldenström's macroglobulinemia.
    Dimopoulos MA; Merlini G; Leblond V; Anagnostopoulos A; Alexanian R
    Haematologica; 2005 Jan; 90(1):117-25. PubMed ID: 15642678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia.
    Treon SP; Gertz MA; Dimopoulos M; Anagnostopoulos A; Blade J; Branagan AR; Garcia-Sanz R; Johnson S; Kimby E; Leblond V; Fermand JP; Maloney DG; Merlini G; Morel P; Morra E; Nichols G; Ocio EM; Owen R; Stone MJ
    Blood; 2006 May; 107(9):3442-6. PubMed ID: 16410453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options in Waldenstrom's macroglobulinemia.
    Björkholm M
    Clin Lymphoma; 2004 Dec; 5(3):155-62. PubMed ID: 15636690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of complete haematological remission after monotherapy with anti-CD20 monoclonal antibody (RITUXIMAB) in a patient with alkylating agent resistant Waldenström's macroglobulinaemia.
    Weide R; Heymanns J; Köppler H
    Leuk Lymphoma; 1999 Dec; 36(1-2):203-6. PubMed ID: 10613467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell transplantation (SCT) for Waldenstrom's macroglobulinemia (WM).
    Anagnostopoulos A; Giralt S
    Bone Marrow Transplant; 2002 Jun; 29(12):943-7. PubMed ID: 12098060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Waldenström's macroglobulinemia. An overview of its clinical, biochemical, immunological and therapeutic features and our series of 121 patients collected in a single center.
    Merchionne F; Procaccio P; Dammacco F
    Crit Rev Oncol Hematol; 2011 Oct; 80(1):87-99. PubMed ID: 21036057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waldenstrom's macroglobulinemia: Recent advances in biology and therapy.
    Neparidze N; Dhodapkar MV
    Clin Adv Hematol Oncol; 2009 Oct; 7(10):677-81, 687-90. PubMed ID: 20040909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia.
    Treon SP; Agus TB; Link B; Rodrigues G; Molina A; Lacy MQ; Fisher DC; Emmanouilides C; Richards AI; Clark B; Lucas MS; Schlossman R; Schenkein D; Lin B; Kimby E; Anderson KC; Byrd JC
    J Immunother; 2001; 24(3):272-9. PubMed ID: 11394506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Waldenström's macroglobulinemia].
    Poulain S; Wemeau M; Balkaran S; Hivert B; Hautecoeur A; Rossignol J; Fernandez J; Daudignon A; Roumier C; Soenen V; Lepelley P; Lai JL; Morel P; Leleu X
    Rev Med Interne; 2010 May; 31(5):385-94. PubMed ID: 20363537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Waldenström macroglobulinemia: my way.
    Gertz M
    Leuk Lymphoma; 2013 Mar; 54(3):464-71. PubMed ID: 22860921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fludarabine in Waldenstrom's macroglobulinemia.
    Souchet-Compain L; Nguyen S; Choquet S; Leblond V
    Expert Rev Hematol; 2013 Jun; 6(3):229-37. PubMed ID: 23782076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Waldenström's macroglobulinemia.
    Dimopoulos MA; Anagnostopoulos A
    Best Pract Res Clin Haematol; 2005; 18(4):747-65. PubMed ID: 16026748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Waldenström macroglobulinemia.
    Ghobrial IM; Witzig TE
    Curr Treat Options Oncol; 2004 Jun; 5(3):239-47. PubMed ID: 15115652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Waldenström macroglobulinemia].
    Telek B; Batár P; Váróczy L; Gergely L; Rejtő L; Szász R; Miltényi Z; Simon Z; Udvardy M; Illés A
    Orv Hetil; 2013 Dec; 154(50):1970-4. PubMed ID: 24317355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.